Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS)

CNY 31.24

(-0.13%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 3.34 Billion 3.01 Billion 2.77 Billion 2.53 Billion 987.08 Million 789.69 Million
Total Current Assets 1.88 Billion 1.7 Billion 1.77 Billion 1.89 Billion 631.29 Million 528.82 Million
Cash And Short Term Investments 1.52 Billion 1.34 Billion 1.5 Billion 1.62 Billion 404.05 Million 364.78 Million
Cash and Cash Equivalents 781.23 Million 830.96 Million 1.05 Billion 1.05 Billion 404.05 Million 364.78 Million
Short Term Investments 741.78 Million 516.36 Million 453.84 Million 570 Million - -
Net Receivables 187.14 Million 198.08 Million 144.87 Million 161.04 Million 154.09 Million 106.29 Million
Inventory 160.98 Million 140.86 Million 103.68 Million 84.02 Million 60.41 Million 51.69 Million
Other Current Assets 11.73 Million 22.84 Million 25.97 Million 23.57 Million 12.73 Million 6.04 Million
Total Non-Current Assets 1.46 Billion 1.3 Billion 996.19 Million 636.91 Million 355.78 Million 260.87 Million
Net PPE 1.25 Billion 1.14 Billion 874.59 Million 571.67 Million 301.08 Million 210.56 Million
Good Will And Intangible Assets 84.45 Million 77 Million 41.75 Million 34.21 Million 35.22 Million 36.04 Million
Good Will - - - - - -
Intangible Assets 84.45 Million 77 Million 41.75 Million 34.21 Million 35.22 Million 36.04 Million
Long-Term Investments -660.7 Million -469.7 Million 4.29 Million 3.41 Million 4.11 Million 520.53 Thousand
Tax Assets 8.56 Million 8.73 Million 12.15 Million 8.72 Million 3.41 Million 3.93 Million
Other Non Current Assets 776.58 Million 551.41 Million 63.39 Million 18.87 Million 11.95 Million 9.8 Million
Other Assets - 1.00 1.00 - 1.00 -
Total Liabilities 743.33 Million 573.08 Million 483.6 Million 435.6 Million 289.63 Million 207.5 Million
Total Current Liabilities 661.09 Million 529.38 Million 432.45 Million 385.27 Million 277.11 Million 192.77 Million
Account Payables 180.93 Million 156.85 Million 203.91 Million 122.73 Million 51.17 Million 31.83 Million
Tax Payables 15.86 Million 14.71 Million 16.76 Million 17.71 Million 14.77 Million 14.35 Million
Short Term Debt 183.88 Million 105.29 Million 20.02 Million 40.02 Million 4.69 Million -19.57 Million
Deferred Revenue 293.76 Million 28.7 Million 203.16 Million 219.22 Million 199.69 Million 19.57 Million
Other Current Liabilities 2.51 Million 238.52 Million 5.35 Million 3.28 Million 21.55 Million 160.93 Million
Total Non Current Liabilities 82.24 Million 43.69 Million 51.14 Million 50.33 Million 12.52 Million 14.72 Million
Long-Term Debt 39.6 Million - - - - -
Deferred Revenue Non Current 41.18 Million 42.81 Million 51.02 Million 50.33 Million 12.52 Million 14.72 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - - - - - -
Other Liabilities 1.00 - 1.00 - - -
Total Equity 2.6 Billion 2.44 Billion 2.29 Billion 2.09 Billion 697.44 Million 582.19 Million
Stock Holders Equity 2.6 Billion 2.44 Billion 2.29 Billion 2.09 Billion 697.44 Million 582.19 Million
Common Stock 120.09 Million 120.09 Million 120.09 Million 120.09 Million 90 Million 90 Million
Retained Earnings 979.58 Million 820.25 Million 667.4 Million 485.65 Million 323.84 Million 247.73 Million
Accumulated other comprehensive income 2.57 Billion 60.06 Million 60.11 Million 45.45 Million 61.2 Million 244.45 Million
Common Stock Equity 2.6 Billion 2.44 Billion 2.29 Billion 2.09 Billion 697.44 Million 582.19 Million
Capital Lease Obligation - - - - - -
Total Investments 81.08 Million 46.65 Million 453.84 Million 570 Million 4.11 Million 520.53 Thousand
Total Debt 223.48 Million 105.29 Million 20.02 Million 40.02 Million 4.69 Million -
Net Debt -557.74 Million -725.67 Million -1.03 Billion -1.01 Billion -399.36 Million -364.78 Million

Balance Sheet Charts